178 related articles for article (PubMed ID: 28460538)
1. Timely reminder interventions to improve annual Papanicolaou (Pap) smear rates among HIV-infected women in an outpatient center of southern Nevada: a short report.
Ganta V; Moonie S; Patel D; Hunt AT; Richardson J; Di John D; Ezeanolue EE
AIDS Care; 2017 Sep; 29(9):1099-1101. PubMed ID: 28460538
[TBL] [Abstract][Full Text] [Related]
2. Frequency of cervical cancer and breast cancer screening in HIV-infected women in a county-based HIV clinic in the Western United States.
Rahangdale L; Sarnquist C; Yavari A; Blumenthal P; Israelski D
J Womens Health (Larchmt); 2010 Apr; 19(4):709-12. PubMed ID: 20201703
[TBL] [Abstract][Full Text] [Related]
3. Cost effective analysis of recall methods for cervical cancer screening in Selangor--results from a prospective randomized controlled trial.
Rashid RM; Ramli S; John J; Dahlui M
Asian Pac J Cancer Prev; 2014; 15(13):5143-7. PubMed ID: 25040965
[TBL] [Abstract][Full Text] [Related]
4. A computerized reminder system improves compliance with Papanicolaou smear recommendations in an HIV care clinic.
Shuter J; Kalkut GE; Pinon MW; Bellin EY; Zingman BS
Int J STD AIDS; 2003 Oct; 14(10):675-80. PubMed ID: 14596771
[TBL] [Abstract][Full Text] [Related]
5. Exploring the feasibility of using mobile phones to improve the management of clients with cervical cancer precursor lesions.
Moodley J; Constant D; Botha MH; van der Merwe FH; Edwards A; Momberg M
BMC Womens Health; 2019 Jan; 19(1):2. PubMed ID: 30616579
[TBL] [Abstract][Full Text] [Related]
6. Low Papanicolaou smear screening rate of women with HIV infection: a nationwide population-based study in Taiwan, 2000-2010.
Chen YC; Liu HY; Li CY; Lee NY; Ko WC; Chou CY; Hsieh TH; Ko NY
J Womens Health (Larchmt); 2013 Dec; 22(12):1016-22. PubMed ID: 23992102
[TBL] [Abstract][Full Text] [Related]
7. How reminders given to patients and physicians affected pap smear use in a health maintenance organization: results of a randomized controlled trial.
Burack RC; Gimotty PA; George J; McBride S; Moncrease A; Simon MS; Dews P; Coombs J
Cancer; 1998 Jun; 82(12):2391-400. PubMed ID: 9635532
[TBL] [Abstract][Full Text] [Related]
8. Study protocol for the most effective recall method in a cervical cancer screening program in Klang, Malaysia.
Abdul Rashid RM; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5867-70. PubMed ID: 24289591
[TBL] [Abstract][Full Text] [Related]
9. Cervical cancer screening among HIV-infected women in a health department setting.
Logan JL; Khambaty MQ; D'Souza KM; Menezes LJ
AIDS Patient Care STDS; 2010 Aug; 24(8):471-5. PubMed ID: 20653483
[TBL] [Abstract][Full Text] [Related]
10. Impact of Patient Reminders on Papanicolaou Test Completion for High-Risk Patients Identified by a Clinical Decision Support System.
MacLaughlin KL; Kessler ME; Komandur Elayavilli R; Hickey BC; Scheitel MR; Wagholikar KB; Liu H; Kremers WK; Chaudhry R
J Womens Health (Larchmt); 2018 May; 27(5):569-574. PubMed ID: 29297754
[TBL] [Abstract][Full Text] [Related]
11. The frequency of Pap smear screening in the United States.
Sirovich BE; Welch HG
J Gen Intern Med; 2004 Mar; 19(3):243-50. PubMed ID: 15009779
[TBL] [Abstract][Full Text] [Related]
12. Mammogram and Pap Smear Uptake Among Women in the HIV Outpatient Study USA, 2010-2021.
Firnhaber C; Simoncini G; Mayer C; Armon C; Ewing AC; Tedaldi E; Battalora L; Carlson K; Chagaris K; Buchacz K; Li J
AIDS Patient Care STDS; 2024 Apr; 38(4):151-154. PubMed ID: 38656216
[No Abstract] [Full Text] [Related]
13. The cervical cancer screening programme in Norway, 1992-2000: changes in Pap smear coverage and incidence of cervical cancer.
Nygård JF; Skare GB; Thoresen SØ
J Med Screen; 2002; 9(2):86-91. PubMed ID: 12133929
[TBL] [Abstract][Full Text] [Related]
14. Screening frequency and histologic type influence the efficacy of cervical cancer screening: A nationwide cohort study.
Chiang YC; Chen YY; Hsieh SF; Chiang CJ; You SL; Cheng WF; Lai MS; Chen CA;
Taiwan J Obstet Gynecol; 2017 Aug; 56(4):442-448. PubMed ID: 28805598
[TBL] [Abstract][Full Text] [Related]
15. Comparison of a self-administered tampon ThinPrep test with conventional pap smears for cervical cytology.
Budge M; Halford J; Haran M; Mein J; Wright G
Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):215-9. PubMed ID: 15904447
[TBL] [Abstract][Full Text] [Related]
16. Mobile phone text messaging intervention for cervical cancer screening: changes in knowledge and behavior pre-post intervention.
Lee HY; Koopmeiners JS; Rhee TG; Raveis VH; Ahluwalia JS
J Med Internet Res; 2014 Aug; 16(8):e196. PubMed ID: 25164545
[TBL] [Abstract][Full Text] [Related]
17. Is the phone call the most effective method for recall in cervical cancer screening?--results from a randomised control trial.
Abdul Rashid RM; Mohamed M; Hamid ZA; Dahlui M
Asian Pac J Cancer Prev; 2013; 14(10):5901-4. PubMed ID: 24289597
[TBL] [Abstract][Full Text] [Related]
18. High prevalence of abnormal Pap smears among young women co-infected with HIV in rural South Africa - implications for cervical cancer screening policies in high HIV prevalence populations.
Gaym A; Mashego M; Kharsany AB; Walldorf J; Frohlich J; Karim QA
S Afr Med J; 2007 Feb; 97(2):120-3. PubMed ID: 17404673
[TBL] [Abstract][Full Text] [Related]
19. [Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].
Spaczyński M; Karowicz-Bilinska A; Rokita W; Molińska-Glura M; Januszek-Michalecka L; Seroczyński P; Uchlik J; Nowak-Markwitz E
Ginekol Pol; 2010 Sep; 81(9):655-63. PubMed ID: 20973201
[TBL] [Abstract][Full Text] [Related]
20. The burden of prevention: downstream consequences of Pap smear testing in the elderly.
Sirovich BE; Gottlieb DJ; Fisher ES
J Med Screen; 2003; 10(4):189-95. PubMed ID: 14738656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
